FR2877946B1 - Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet - Google Patents

Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet

Info

Publication number
FR2877946B1
FR2877946B1 FR0412045A FR0412045A FR2877946B1 FR 2877946 B1 FR2877946 B1 FR 2877946B1 FR 0412045 A FR0412045 A FR 0412045A FR 0412045 A FR0412045 A FR 0412045A FR 2877946 B1 FR2877946 B1 FR 2877946B1
Authority
FR
France
Prior art keywords
maurocalcin
vectors
molecules
interest
derived peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0412045A
Other languages
English (en)
French (fr)
Other versions
FR2877946A1 (fr
Inventor
Michel Ronjat
Waard Michel De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0412045A priority Critical patent/FR2877946B1/fr
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to CA002586811A priority patent/CA2586811A1/fr
Priority to US11/719,171 priority patent/US8207293B2/en
Priority to AU2005303623A priority patent/AU2005303623A1/en
Priority to PCT/FR2005/002817 priority patent/WO2006051224A1/fr
Priority to CNA2005800457088A priority patent/CN101094863A/zh
Priority to JP2007540681A priority patent/JP5416901B2/ja
Priority to EP05817457.4A priority patent/EP1814905B1/fr
Publication of FR2877946A1 publication Critical patent/FR2877946A1/fr
Priority to IL183022A priority patent/IL183022A0/en
Application granted granted Critical
Publication of FR2877946B1 publication Critical patent/FR2877946B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR0412045A 2004-11-12 2004-11-12 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet Expired - Fee Related FR2877946B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0412045A FR2877946B1 (fr) 2004-11-12 2004-11-12 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet
US11/719,171 US8207293B2 (en) 2004-11-12 2005-11-14 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
AU2005303623A AU2005303623A1 (en) 2004-11-12 2005-11-14 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
PCT/FR2005/002817 WO2006051224A1 (fr) 2004-11-12 2005-11-14 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet
CA002586811A CA2586811A1 (fr) 2004-11-12 2005-11-14 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet
CNA2005800457088A CN101094863A (zh) 2004-11-12 2005-11-14 用作细胞内转运目标分子用载体的毛若考辛衍生多肽
JP2007540681A JP5416901B2 (ja) 2004-11-12 2005-11-14 興味のある分子の細胞内位置決めのためのベクターとして用いられるマウロカルシン由来ペプチド
EP05817457.4A EP1814905B1 (fr) 2004-11-12 2005-11-14 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet
IL183022A IL183022A0 (en) 2004-11-12 2007-05-06 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0412045A FR2877946B1 (fr) 2004-11-12 2004-11-12 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet

Publications (2)

Publication Number Publication Date
FR2877946A1 FR2877946A1 (fr) 2006-05-19
FR2877946B1 true FR2877946B1 (fr) 2011-02-11

Family

ID=34953760

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0412045A Expired - Fee Related FR2877946B1 (fr) 2004-11-12 2004-11-12 Peptides derives de la maurocalcine utilisables comme vecteurs pour l'adressage intracellulaire de molecules d'interet

Country Status (9)

Country Link
US (1) US8207293B2 (enExample)
EP (1) EP1814905B1 (enExample)
JP (1) JP5416901B2 (enExample)
CN (1) CN101094863A (enExample)
AU (1) AU2005303623A1 (enExample)
CA (1) CA2586811A1 (enExample)
FR (1) FR2877946B1 (enExample)
IL (1) IL183022A0 (enExample)
WO (1) WO2006051224A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2537858A1 (en) 2011-06-20 2012-12-26 Commissariat à l'Énergie Atomique et aux Énergies Alternatives Small efficient cell penetrating peptides derived from the scorpion toxin maurocalcine
WO2014141124A1 (en) 2013-03-13 2014-09-18 Institut National De La Sante Et De La Recherche Medicale Erk-pathway activating compound for preventing or treating leptin resistance
CA2906663A1 (en) 2013-03-15 2014-09-18 Techulon Inc. Antisense molecules for treatment of staphylococcus aureus infection
JP6600621B2 (ja) 2013-03-15 2019-10-30 テチュロン インコーポレイテッド 黄色ブドウ球菌感染の治療のためのアンチセンス分子
PL3007717T3 (pl) * 2013-06-12 2018-12-31 Pharis Biotec Gmbh Peptydy o antagonistycznej aktywności w stosunku do naturalnego CXCR4
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
CN105087492B (zh) * 2015-07-16 2021-04-13 中国人民解放军军事医学科学院放射与辐射医学研究所 培养原代海马神经元的方法
JP6966424B2 (ja) 2015-09-09 2021-11-17 フレッド ハッチンソン キャンサー リサーチ センター 軟骨ホーミングペプチド
CA3005928A1 (en) * 2015-12-11 2017-06-15 Fred Hutchinson Cancer Research Center Peptides for renal therapy
WO2018136614A1 (en) 2017-01-18 2018-07-26 Fred Hutchinson Cancer Research Center Peptide compositions and methods of use thereof for disrupting tead interactions
CN110475565A (zh) 2017-03-16 2019-11-19 光明之火生物科学公司 软骨归巢肽缀合物及其使用方法
WO2018232122A1 (en) 2017-06-15 2018-12-20 Blaze Bioscience, Inc. Renal-homing peptide conjugates and methods of use thereof
CA3086040A1 (en) 2017-12-19 2019-06-27 Blaze Bioscience, Inc. Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051429A (en) * 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
EP1114060B1 (en) * 1998-09-15 2003-06-11 NIZO food research Process for producing peptides from biological fluids and peptides obtainable by said process
GB0005124D0 (en) * 2000-03-03 2000-04-26 Cellpep Sa Maurocalcin,analogues thereof and their therapeutical uses
DE60331437D1 (de) * 2002-06-10 2010-04-08 Amylin Pharmaceuticals Inc Nachspaltige sulfurentschützung zur konvergenten proteinherstellung beim verfahren von chemischer ligation
SE0201863D0 (en) 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides

Also Published As

Publication number Publication date
AU2005303623A1 (en) 2006-05-18
FR2877946A1 (fr) 2006-05-19
EP1814905B1 (fr) 2013-04-17
JP2008519592A (ja) 2008-06-12
IL183022A0 (en) 2007-09-20
EP1814905A1 (fr) 2007-08-08
JP5416901B2 (ja) 2014-02-12
US8207293B2 (en) 2012-06-26
WO2006051224A1 (fr) 2006-05-18
CN101094863A (zh) 2007-12-26
CA2586811A1 (fr) 2006-05-18
US20090142266A1 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
IL183022A0 (en) Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest
EP1784196A4 (en) CERAMID DERIVATIVES AS MODULATORS OF IMMUNITY AND AUTOIMMUNITY
FR2854897B1 (fr) Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
EP2008640A4 (en) LIQUID MAKE-UP COSMETICS ON WATER BASIS
EP1699756A4 (en) SYNTHESIS OF IONIC LIQUIDS
EP2059123A4 (en) FORMULATIONS FROM PICKERING EMULSIONS
EP2068624A4 (en) FORMULATIONS FROM PICKERING EMULSIONS
EP1937434A4 (en) COATING COMPOSITIONS FOR CONTAINERS AND COATING PROCESSES
FR13C0015I2 (fr) Composes d'aminoheteroaryle enantiomeriquement purs utilises comme inhibiteurs de proteine kinase
WO2005014049A3 (en) Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides
EP1841890A4 (en) PRIMER FOR NUCLEIC ACID DETERGENT
EP1736263A4 (en) CLAMPING STRUCTURE FOR DISPOSABLE TIP
EP1970753A4 (en) IDENTIFICATION MEDIUM
EP1746141A4 (en) THICKENER
EP1701948A4 (en) ASSAY FOR DETECTOGEN
EP1776863A4 (en) AGRICULTURAL CHEMICALS COMPOSITION
FR2914311B1 (fr) Modification de la nuance colorante d'anthocyanes pour l'obtention de substances colorantes
EP1958162A4 (en) ANTI-ALIAS TECHNIQUE FOR VECTOR GRAPHICS
EP1861523A4 (en) ANODE SUPPORTING DEVICE
EP1906962A4 (en) OCTAHYDROISOCHINOLIN COMPOUNDS AS OPIOID RECEPTOR MODULATORS
FR2905070B1 (fr) Composition cosmetique pour l'eclaicissement ou l'homogeneisation du teint
DE502005005622D1 (de) Emulgatorkonzentrat für kosmetische zusammensetzung
FR2859627B1 (fr) Composition cosmetique sous forme d'emulsion e/h
FR2890671B3 (fr) Plaque d'egout universelle pour route de type reglable
EP1756276A4 (en) KRUST ANIMAL EXPRESSION VECTOR

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160729